SCF REVERSE ENGINEERING & PATHWAY REALIGNMENT REPORT
PROJECT AMMONEX-HE
Compound-to-Target Reconstruction for Hepatic Encephalopathy Ammonia Modulation
Document Code: SCF-AMMONEX-HE-RE-0001
Stage: Discovery → Hit-to-Lead Optimization
Objective:
Deconstruct the highest-ranked ethnobioprospecting candidates into molecular components, map them against the HE ammonia fault architecture, and nominate development-candidate scaffolds for preclinical advancement.
Methodology follows SCF Reverse Engineering & Pathway Realignment principles.
SECTION I — REVERSE ENGINEERED THERAPEUTIC CONTROL NETWORK
Control Node CN-1
Gut Ammonia Production
Primary Targets:
- Bacterial urease
- Protein fermentation pathways
- TLR4
- NF-κB
Desired Outcome:
- Reduced intestinal ammonia generation
- Reduced endotoxin burden
Control Node CN-2
Hepatic Nitrogen Metabolism
Primary Targets:
- CPS1
- OTC
- ASS1
- ARG1
- GLUL
Desired Outcome:
- Increased ammonia clearance
- Enhanced urea-cycle efficiency
Control Node CN-3
Barrier Integrity
Primary Targets:
- Zonulin
- Claudin-1
- Occludin
- Mucin pathways
Desired Outcome:
- Reduced microbial translocation
- Reduced inflammatory amplification
Control Node CN-4
Astrocyte Protection
Primary Targets:
- Aquaporin-4
- Glutamine accumulation pathways
- Mitochondrial ROS generation
Desired Outcome:
- Reduced astrocyte swelling
- Reduced cerebral edema risk
Control Node CN-5
Neuroimmune Stabilization
Primary Targets:
- NLRP3
- TNF-α
- IL-6
- NF-κB
Desired Outcome:
- Reduced neuroinflammation
- Improved neural signaling
SECTION II — COMPOUND-LEVEL DECONSTRUCTION
LEAD SOURCE 1
Phyllanthus niruri
Major Compound Families
Class | Representative Molecules |
Lignans | Phyllanthin |
Lignans | Hypophyllanthin |
Polyphenols | Ellagic acid |
Flavonoids | Quercetin derivatives |
Tannins | Corilagin |
Reverse-Engineered Functions
Compound | Potential HE Node |
Phyllanthin | CN-2 |
Hypophyllanthin | CN-2 |
Corilagin | CN-5 |
Ellagic acid | CN-3 / CN-5 |
SCF Role
Primary Hepatic Metabolic Regulator
LEAD SOURCE 2
Genipa americana
Major Compound Families
Class | Representative Molecules |
Iridoids | Geniposide |
Iridoids | Genipin |
Polyphenols | Phenolic acids |
Reverse-Engineered Functions
Compound | Potential HE Node |
Geniposide | CN-2 |
Genipin | CN-3 |
Phenolic acids | CN-5 |
SCF Role
Nitrogen Metabolism Restoration
Database identifies Genipa as a hepatoprotective lead.
LEAD SOURCE 3
Croton lechleri
Major Compound Families
Class | Representative Molecules |
Alkaloids | Taspine |
Polyphenols | Proanthocyanidins |
Reverse-Engineered Functions
Compound | Potential HE Node |
Taspine | CN-3 |
Proanthocyanidins | CN-3 / CN-5 |
SCF Role
Barrier Integrity Modulator
Database designates taspine as a major active constituent.
LEAD SOURCE 4
Scutellaria baicalensis
Major Compound Families
Class | Representative Molecules |
Flavones | Baicalin |
Flavones | Baicalein |
Flavones | Wogonin |
Reverse-Engineered Functions
Compound | Potential HE Node |
Baicalin | CN-5 |
Baicalein | CN-5 |
Wogonin | CN-4 / CN-5 |
SCF Role
Neuroimmune Stabilizer
LEAD SOURCE 5
Coptis chinensis
Major Compound Families
Class | Representative Molecules |
Isoquinoline alkaloids | Berberine |
Isoquinoline alkaloids | Coptisine |
Isoquinoline alkaloids | Palmatine |
Reverse-Engineered Functions
Compound | Potential HE Node |
Berberine | CN-1 |
Coptisine | CN-1 |
Palmatine | CN-1 / CN-5 |
SCF Role
Gut Ammonia Suppression
SECTION III — MOLECULAR TARGET CONVERGENCE MAP
Highest Convergence Compounds
Compound | CN-1 | CN-2 | CN-3 | CN-4 | CN-5 |
Berberine | ✓ | — | ✓ | — | ✓ |
Geniposide | — | ✓ | ✓ | — | ✓ |
Phyllanthin | — | ✓ | — | — | ✓ |
Corilagin | — | ✓ | ✓ | — | ✓ |
Baicalin | — | — | — | ✓ | ✓ |
Taspine | — | — | ✓ | — | ✓ |
SECTION IV — LEAD SCAFFOLD NOMINATION
Candidate Scaffold A
AMX-201
Working Chemical Class
Geniposide–Phyllanthin Hybrid
Therapeutic Intent
- Hepatic ammonia clearance
- Nitrogen metabolism restoration
Development Priority
Very High
Candidate Scaffold B
AMX-202
Working Chemical Class
Berberine–Geniposide Hybrid
Therapeutic Intent
- Gut ammonia suppression
- Hepatic metabolic support
Development Priority
Very High
Candidate Scaffold C
AMX-203
Working Chemical Class
Baicalin–Genipin Hybrid
Therapeutic Intent
- Astrocyte protection
- Neuroinflammatory suppression
Development Priority
High
SECTION V — DEVELOPMENT CANDIDATE NOMINATION
AMX-202
Recommended Primary Development Candidate
Rationale
Among the reconstructed candidates, AMX-202 theoretically covers:
HE Control Node | Coverage |
CN-1 | Strong |
CN-2 | Strong |
CN-3 | Moderate |
CN-4 | Moderate |
CN-5 | Strong |
This provides the broadest mechanistic coverage of the identified HE fault architecture.
SECTION VI — HIT-TO-LEAD OPTIMIZATION STRATEGY
Phase A
Target Validation
- Urease assays
- Hepatocyte nitrogen-metabolism assays
- Barrier integrity models
Phase B
Lead Optimization
- Solubility enhancement
- Oral exposure optimization
- Gut-retention tuning
- Hepatic-targeting strategies
Phase C
Preclinical Candidate Selection
Selection criteria:
- Plasma ammonia reduction
- Neuroprotection
- PK profile
- Safety margins
SECTION VII — REFINED SCF FIBONACCI STACK
Role | Candidate |
Target Modulator | Berberine scaffold |
Safety Harmonizer | Ganoderma β-glucans |
Metabolic Stabilizer | Geniposide |
Metabolic Stabilizer | Phyllanthin |
Absorption Enhancer | Phospholipid complex |
Absorption Enhancer | Inulin matrix |
Absorption Enhancer | MCT carrier |
Supportive Agent | Baicalin |
Supportive Agent | Taspine fraction |
Supportive Agent | Corilagin |
Supportive Agent | Ellagic acid |
Supportive Agent | Polyphenol fraction |
STRATEGIC NEXT STAGE
Trigger Command
LEAD OPTIMIZATION
Outputs:
- AMX-202 Development Candidate Package
- ADME/PK Modeling
- CMC Feasibility Assessment
- Toxicology Risk Matrix
- IND-Enabling Study Plan
- First-in-Human Starting Dose Framework
MASTER REGISTRY INDEX
SCF-AMMONEX-HE-RE-0001 — Reverse Engineering Report
SCF-AMMONEX-HE-AMX202-0002 — Development Candidate Program
SCF-AMMONEX-HE-H2L-0003 — Hit-to-Lead Optimization
SCF-AMMONEX-HE-PK-0004 — PK Engineering Program
SCF-AMMONEX-HE-IND-0005 — IND Translation Architecture
SCF-AMMONEX-HE-FIB-0006 — Fibonacci Therapeutic Stack Design